Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology
1998

VEGF Release from Platelets and Its Importance in Cancer

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): RE Banks, MA Forbes, SE Kinsey, A Stanley, E Ingham, C Walters, PJ Selby

Primary Institution: ICRF Cancer Medicine Research Unit, St James's University Hospital, Leeds, UK

Hypothesis

Is the higher concentration of VEGF in serum compared to plasma due to its release from platelets during coagulation?

Conclusion

The study found that serum VEGF concentrations are significantly higher than those in matched plasma due to the release of VEGF from activated platelets.

Supporting Evidence

  • Serum VEGF concentrations ranged from 76 to 854 pg/ml.
  • Matched plasma VEGF concentrations ranged from <9 to 42 pg/ml.
  • Clotting of platelet-rich plasma resulted in higher VEGF levels of 38-505 pg/ml.

Takeaway

When blood clots, platelets release a substance called VEGF, which helps in forming new blood vessels. This is important for understanding how cancer spreads.

Methodology

Blood samples were taken from healthy volunteers, processed into serum and plasma, and VEGF levels were measured using ELISA.

Potential Biases

Potential bias due to the small sample size and the specific demographic of healthy volunteers.

Limitations

The study was limited to a small sample size of healthy volunteers and may not represent all populations.

Participant Demographics

Eight healthy volunteers aged between 21 and 56 years, both male and female.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication